Quantamental Technologies’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-862
Closed -$207K 470
2023
Q2
$207K Buy
+862
New +$179K 0.09% 388
2023
Q1
Sell
-3,015
Closed -$640K 536
2022
Q4
$640K Buy
+3,015
New +$602K 0.29% 120
2022
Q2
Sell
-2,330
Closed -$381K 499
2022
Q1
$381K Buy
2,330
+331
+17% +$54.6K 0.22% 180
2021
Q4
$435K Buy
+1,999
New +$419K 0.22% 179
2019
Q4
Sell
-3,552
Closed -$299K 954
2019
Q3
$299K Sell
3,552
-3,113
-47% -$235K 0.1% 347
2019
Q2
$436K Buy
6,665
+5,846
+714% +$337K 0.16% 181
2019
Q1
$48K Sell
819
-6,081
-88% -$363K 0.02% 883
2018
Q4
$365K Buy
+6,900
New +$379K 0.22% 98

Other funds holding MEDP

Quantamental Technologies's MEDP Position: Q3 2023 in Review

Quantamental Technologies sold out of Medpace (MEDP) in Q3 2023, closing a stake of 862 shares — an estimated $207K sold.

Quantamental Technologies first reported a position in MEDP in Q4 2018 and held it in 8 quarters. The position peaked at $640K in Q4 2022. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

  • Quantamental Technologies reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 862 Medpace shares in Q3 2023, an estimated $207K.
  • Quantamental Technologies first reported a position in Medpace in Q4 2018 and held it in 8 quarters.
  • Quantamental Technologies's Medpace position peaked at $640K in Q4 2022.
  • 488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.